Cargando…
Comment on “Aripiprazole Plasma Concentrations Delivered from Two 2-Month Long-Acting Injectable Formulations: An Indirect Comparison” [Letter]
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10402714/ https://www.ncbi.nlm.nih.gov/pubmed/37546516 http://dx.doi.org/10.2147/NDT.S430757 |
| _version_ | 1785084901320556544 |
|---|---|
| author | Rege, Bhaskar Meyer, Jonathan M |
| author_facet | Rege, Bhaskar Meyer, Jonathan M |
| author_sort | Rege, Bhaskar |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10402714 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Dove |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104027142023-08-05 Comment on “Aripiprazole Plasma Concentrations Delivered from Two 2-Month Long-Acting Injectable Formulations: An Indirect Comparison” [Letter] Rege, Bhaskar Meyer, Jonathan M Neuropsychiatr Dis Treat Letter Dove 2023-07-31 /pmc/articles/PMC10402714/ /pubmed/37546516 http://dx.doi.org/10.2147/NDT.S430757 Text en © 2023 Rege and Meyer. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
| spellingShingle | Letter Rege, Bhaskar Meyer, Jonathan M Comment on “Aripiprazole Plasma Concentrations Delivered from Two 2-Month Long-Acting Injectable Formulations: An Indirect Comparison” [Letter] |
| title | Comment on “Aripiprazole Plasma Concentrations Delivered from Two 2-Month Long-Acting Injectable Formulations: An Indirect Comparison” [Letter] |
| title_full | Comment on “Aripiprazole Plasma Concentrations Delivered from Two 2-Month Long-Acting Injectable Formulations: An Indirect Comparison” [Letter] |
| title_fullStr | Comment on “Aripiprazole Plasma Concentrations Delivered from Two 2-Month Long-Acting Injectable Formulations: An Indirect Comparison” [Letter] |
| title_full_unstemmed | Comment on “Aripiprazole Plasma Concentrations Delivered from Two 2-Month Long-Acting Injectable Formulations: An Indirect Comparison” [Letter] |
| title_short | Comment on “Aripiprazole Plasma Concentrations Delivered from Two 2-Month Long-Acting Injectable Formulations: An Indirect Comparison” [Letter] |
| title_sort | comment on “aripiprazole plasma concentrations delivered from two 2-month long-acting injectable formulations: an indirect comparison” [letter] |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10402714/ https://www.ncbi.nlm.nih.gov/pubmed/37546516 http://dx.doi.org/10.2147/NDT.S430757 |
| work_keys_str_mv | AT regebhaskar commentonaripiprazoleplasmaconcentrationsdeliveredfromtwo2monthlongactinginjectableformulationsanindirectcomparisonletter AT meyerjonathanm commentonaripiprazoleplasmaconcentrationsdeliveredfromtwo2monthlongactinginjectableformulationsanindirectcomparisonletter |